prednisolone has been researched along with Spinal Fractures in 27 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Spinal Fractures: Broken bones in the vertebral column.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Glucocorticoid treatment for steroid-dependent nephrotic syndrome (NS) is associated with severe adverse effects, such as bone fractures and epidural lipomatosis." | 5.32 | Effectiveness of high trough levels of cyclosporine for 5 months in a case of steroid-dependent nephrotic syndrome with severe steroid toxicity. ( Arisaka, O; Kano, K; Nishikura, K; Shimizu, A; Shiraiwa, T; Tomita, S; Ueda, Y; Yamada, Y, 2004) |
| "The aim of the study was an analysis of the frequency of oral steroids prescription to patients with bronchial asthma treated in hospital and of vertebral fractures and deformations as the result of GCS-induced osteoporosis in patients with bronchial asthma taking prednisolone tablets for at least 6 months." | 3.70 | [Osteoporotic fracture of the vertebral body in patients with steroid dependent bronchial asthma]. ( Lebedeva, MK; Lesniak, OM; Lezhnina, MB; Piven', AI, 2000) |
| "The adverse effects of oral corticosteroids are widely recognised but there are few quantitative data on which to base advice to patients." | 2.70 | Adverse effects of oral corticosteroids in relation to dose in patients with lung disease. ( Cooper, S; Hubbard, R; Lewis, SA; Oborne, J; Pringle, M; Tattersfield, AE; Walsh, LJ; Wong, CA, 2001) |
| "Systemic mastocytosis is a rare cause of vertebral fractures in young men." | 1.35 | Multimodal therapy for vertebral involvement of systemic mastocytosis. ( Brendel, C; Hamann, C; Hofbauer, LC; Krüger, A; Neubauer, A; Ramaswamy, A; Schnabel, M, 2009) |
| "4), while the risk factor for OFH was a recent maximum GC dosage (>1." | 1.35 | Notable difference between the development of vertebral fracture and osteonecrosis of the femoral head in patients treated with high-dose glucocorticoids for systemic rheumatic diseases. ( Amano, K; Kameda, H; Nagasawa, H; Ogawa, H; Sekiguchi, N; Suzuki, K; Takei, H; Takeuchi, T, 2009) |
| "Glucocorticoid treatment for steroid-dependent nephrotic syndrome (NS) is associated with severe adverse effects, such as bone fractures and epidural lipomatosis." | 1.32 | Effectiveness of high trough levels of cyclosporine for 5 months in a case of steroid-dependent nephrotic syndrome with severe steroid toxicity. ( Arisaka, O; Kano, K; Nishikura, K; Shimizu, A; Shiraiwa, T; Tomita, S; Ueda, Y; Yamada, Y, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (7.41) | 18.2507 |
| 2000's | 17 (62.96) | 29.6817 |
| 2010's | 8 (29.63) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wong, SC | 1 |
| Catto-Smith, AG | 1 |
| Zacharin, M | 1 |
| Omata, Y | 1 |
| Hagiwara, F | 1 |
| Nishino, J | 1 |
| Matsudaira, K | 1 |
| Kadono, Y | 1 |
| Juji, T | 1 |
| Mori, T | 1 |
| Nakayama, H | 1 |
| Nagase, Y | 1 |
| Hirose, J | 1 |
| Yasui, T | 1 |
| Matsumoto, T | 1 |
| Matsui, T | 1 |
| Tohma, S | 1 |
| Tanaka, S | 1 |
| Ishida, O | 1 |
| Furuya, T | 1 |
| Inoue, E | 1 |
| Ochi, K | 1 |
| Ikari, K | 1 |
| Taniguchi, A | 1 |
| Yamanaka, H | 1 |
| Momohara, S | 1 |
| Wang, B | 1 |
| Guo, H | 1 |
| Yuan, L | 1 |
| Huang, D | 1 |
| Zhang, H | 1 |
| Hao, D | 1 |
| Ashida, A | 1 |
| Fujii, Y | 1 |
| Matsumura, H | 1 |
| Tamai, H | 1 |
| Hélaine, L | 1 |
| Cadic, A | 1 |
| Magro, E | 1 |
| Simon, A | 1 |
| Kiss, G | 1 |
| Gueret, G | 1 |
| Arvieux, CC | 1 |
| Sugiyama, T | 3 |
| Tatsuno, I | 3 |
| Suzuki, S | 3 |
| Yoshida, T | 3 |
| Tanaka, T | 3 |
| Sueishi, M | 3 |
| Saito, Y | 1 |
| Hayashi, K | 1 |
| Yamamoto, M | 1 |
| Murakawa, Y | 1 |
| Yamauchi, M | 2 |
| Kaji, H | 2 |
| Yamaguchi, T | 1 |
| Sugimoto, T | 2 |
| Krüger, A | 1 |
| Hamann, C | 1 |
| Brendel, C | 1 |
| Ramaswamy, A | 1 |
| Schnabel, M | 1 |
| Neubauer, A | 1 |
| Hofbauer, LC | 1 |
| Kameda, H | 1 |
| Amano, K | 1 |
| Nagasawa, H | 1 |
| Ogawa, H | 1 |
| Sekiguchi, N | 1 |
| Takei, H | 1 |
| Suzuki, K | 1 |
| Takeuchi, T | 1 |
| Phillips, PJ | 1 |
| Burnet, S | 1 |
| Suyama, K | 2 |
| Mayama, T | 1 |
| Hashimoto, N | 1 |
| Tsugeno, H | 2 |
| Fujita, T | 1 |
| Goto, B | 1 |
| Sugishita, T | 1 |
| Hosaki, Y | 1 |
| Ashida, K | 1 |
| Mitsunobu, F | 1 |
| Tanizaki, Y | 1 |
| Shiratori, Y | 1 |
| Walsh, LJ | 2 |
| Lewis, SA | 2 |
| Wong, CA | 2 |
| Cooper, S | 2 |
| Oborne, J | 2 |
| Cawte, SA | 1 |
| Harrison, T | 1 |
| Green, DJ | 1 |
| Pringle, M | 2 |
| Hubbard, R | 2 |
| Tattersfield, AE | 2 |
| Tanaka, I | 1 |
| Oshima, H | 1 |
| Kano, K | 1 |
| Yamada, Y | 1 |
| Shiraiwa, T | 1 |
| Shimizu, A | 1 |
| Nishikura, K | 1 |
| Arisaka, O | 1 |
| Tomita, S | 1 |
| Ueda, Y | 1 |
| Bassingthwaighte, C | 1 |
| Bird, S | 1 |
| Chihara, K | 1 |
| Lezhnina, MB | 1 |
| Lesniak, OM | 1 |
| Piven', AI | 1 |
| Lebedeva, MK | 1 |
| Sambrook, P | 1 |
| Raj, A | 1 |
| Hunter, D | 1 |
| Naganathan, V | 1 |
| Mason, R | 1 |
| Robinson, B | 1 |
| de Nijs, RN | 1 |
| Jacobs, JW | 1 |
| Bijlsma, JW | 1 |
| Lems, WF | 1 |
| Laan, RF | 1 |
| Houben, HH | 1 |
| ter Borg, EJ | 1 |
| Huisman, AM | 1 |
| Bruyn, GA | 1 |
| van Oijen, PL | 1 |
| Westgeest, AA | 1 |
| Algra, A | 1 |
| Hofman, DM | 1 |
| Gallacher, SJ | 1 |
| Fenner, JA | 1 |
| Anderson, K | 1 |
| Adamson, BB | 1 |
| Banham, SW | 1 |
| Boyle, IT | 1 |
| Curley, RK | 1 |
| Holden, CA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Bone Density in Children With IBD Treated With Amorphous Calcium or Commercial Crystalline Calcium: A Prospective Randomized Multicenter Trial[NCT02470663] | 0 participants (Actual) | Interventional | 2015-07-31 | Withdrawn (stopped due to company and Sheba did not reach an agreement) | |||
| Radiofrequency Ablation of the Medial Branch Nerve as a Novel Treatment for Posterior Element Pain From Vertebral Compression Fractures[NCT03651804] | Phase 4 | 60 participants (Anticipated) | Interventional | 2019-04-10 | Suspended (stopped due to Difficulty recruiting members) | ||
| Vertebral Fracture and Osteonecrosis of the Femoral Head Associated With High-dose Glucocorticoid Therapy[NCT00679978] | 60 participants (Actual) | Observational | 2001-01-31 | Completed | |||
| "Reduction of Corticosteroid Use in Outpatient Treatment of Exacerbated COPD - a Randomized, Double-blind, Non-inferiority Study (The RECUT-Trial)"[NCT02386735] | 470 participants (Anticipated) | Interventional | 2015-03-31 | Recruiting | |||
| A Prospective Baseline Assessment of the Risk of Osteoporosis in Patients With Chronic Obstructive Lung Disease and Outcomes After 2 Years; a Pilot Study[NCT01161680] | 30 participants (Actual) | Observational | 2010-07-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for prednisolone and Spinal Fractures
| Article | Year |
|---|---|
Pathological fractures in paediatric patients with inflammatory bowel disease.
Topics: Adolescent; Body Height; Body Weight; Bone Density; Child; Colitis, Ulcerative; Crohn Disease; Dipho | 2014 |
[Recommendations for the diagnosis and treatment of glucocorticoid-induced osteoporosis].
Topics: Bone Density; Bone Resorption; Diphosphonates; Glucocorticoids; Humans; Practice Guidelines as Topic | 2004 |
6 trials available for prednisolone and Spinal Fractures
| Article | Year |
|---|---|
Vertebral fractures affect functional status in postmenopausal rheumatoid arthritis patients.
Topics: Aged; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Bone Density; Bone Density Conservation Agent | 2014 |
A prospective randomized controlled study comparing the pain relief in patients with osteoporotic vertebral compression fractures with the use of vertebroplasty or facet blocking.
Topics: Aged; Aged, 80 and over; Anesthetics, Local; Back Pain; Disability Evaluation; Female; Fractures, Co | 2016 |
Glucocorticoid excess affects cortical bone geometry in premenopausal, but not postmenopausal, women.
Topics: Administration, Oral; Adult; Cushing Syndrome; Dose-Response Relationship, Drug; Female; Glucocortic | 2008 |
Adverse effects of oral corticosteroids in relation to dose in patients with lung disease.
Topics: Administration, Oral; Aged; Asthma; Cross-Sectional Studies; Dose-Response Relationship, Drug; Femal | 2001 |
Osteoporosis with low dose corticosteroids: contribution of underlying disease effects and discriminatory ability of ultrasound versus bone densitometry.
Topics: Absorptiometry, Photon; Bone Density; Female; Fractures, Spontaneous; Glucocorticoids; Humans; Male; | 2001 |
Prevalence of vertebral deformities and symptomatic vertebral fractures in corticosteroid treated patients with rheumatoid arthritis.
Topics: Aged; Arthritis, Rheumatoid; Cross-Sectional Studies; Female; Glucocorticoids; Humans; Male; Middle | 2001 |
19 other studies available for prednisolone and Spinal Fractures
| Article | Year |
|---|---|
Risk factors for established vertebral fractures in Japanese patients with rheumatoid arthritis: Results from a large prospective observational cohort study.
Topics: Adult; Age Factors; Aged; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Female; Humans; Incidence | 2015 |
A case of multiple vertebral compression fractures due to glucocorticoid-induced osteoporosis in a pediatric patient with nephrotic syndrome
.
Topics: Bone Density; Child; Drug Administration Schedule; Fractures, Compression; Glucocorticoids; Humans; | 2017 |
[Vision loss after spine surgery: a case report].
Topics: Accidental Falls; Adult; Alcoholic Intoxication; Blindness; Fracture Fixation, Internal; Humans; Mal | 2009 |
Incidence of symptomatic vertebral fracture with high-dose glucocorticoid treatment in the Chiba-Shimoshizu Rheumatic Cohort between 1986 and 2006.
Topics: Adult; Aged; Cohort Studies; Collagen Diseases; Female; Glucocorticoids; Humans; Incidence; Japan; M | 2009 |
Bone fragility in male glucocorticoid-induced osteoporosis is not defined by bone mineral density.
Topics: Absorptiometry, Photon; Adult; Aged; Aged, 80 and over; Body Mass Index; Bone Density; Drug Administ | 2009 |
Multimodal therapy for vertebral involvement of systemic mastocytosis.
Topics: Adult; Back Pain; Biomarkers; Biopsy; Bone Density; Bone Density Conservation Agents; Diphosphonates | 2009 |
Notable difference between the development of vertebral fracture and osteonecrosis of the femoral head in patients treated with high-dose glucocorticoids for systemic rheumatic diseases.
Topics: Bone Density; Bone Density Conservation Agents; Etidronic Acid; Female; Femur Head Necrosis; Glucoco | 2009 |
Belinda's back pain.
Topics: Absorptiometry, Photon; Adult; Back Pain; Bone Density; Bone Density Conservation Agents; Diphosphon | 2010 |
Incidence of symptomatic vertebral fractures in women of childbearing age newly treated with high-dose glucocorticoid.
Topics: Adolescent; Adult; Age Factors; Analysis of Variance; Cardiovascular Diseases; Cohort Studies; Confi | 2010 |
Age, initial dose and dose increase are independent risk factors for symptomatic vertebral fractures in glucocorticoid-treated male patients.
Topics: Adult; Age Factors; Aged; Autoimmune Diseases; Case-Control Studies; Cohort Studies; Dose-Response R | 2011 |
Vertebral fracture and cortical bone changes in corticosteroid-induced osteoporosis.
Topics: Administration, Oral; Aged; Anti-Asthmatic Agents; Asthma; Beclomethasone; Bone and Bones; Bone Dens | 2002 |
The impact of oral corticosteroid use on bone mineral density and vertebral fracture.
Topics: Administration, Inhalation; Administration, Oral; Age Distribution; Aged; Aged, 80 and over; Bone De | 2002 |
The impact of oral corticosteroid use on bone mineral density and vertebral fracture.
Topics: Administration, Inhalation; Administration, Oral; Age Distribution; Aged; Aged, 80 and over; Bone De | 2002 |
The impact of oral corticosteroid use on bone mineral density and vertebral fracture.
Topics: Administration, Inhalation; Administration, Oral; Age Distribution; Aged; Aged, 80 and over; Bone De | 2002 |
The impact of oral corticosteroid use on bone mineral density and vertebral fracture.
Topics: Administration, Inhalation; Administration, Oral; Age Distribution; Aged; Aged, 80 and over; Bone De | 2002 |
[The patient suffers from rheumatism for many years. It also makes the bones brittle].
Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Diphosphonates; Female; Glucocorticoids; Humans; Ma | 2002 |
Effectiveness of high trough levels of cyclosporine for 5 months in a case of steroid-dependent nephrotic syndrome with severe steroid toxicity.
Topics: Child, Preschool; Cyclosporine; Female; Glucocorticoids; Humans; Lipomatosis; Nephrotic Syndrome; Pr | 2004 |
Rufo v Hosking [2004] NSWCA 391.
Topics: Dexamethasone; Humans; Lupus Erythematosus, Systemic; Malpractice; New South Wales; Osteoporosis; Pr | 2005 |
Loss of chance: what loss?
Topics: Adolescent; Allergy and Immunology; Dexamethasone; Family Practice; Female; Glucocorticoids; Humans; | 2006 |
[Osteoporotic fracture of the vertebral body in patients with steroid dependent bronchial asthma].
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Asthma; Female; H | 2000 |
Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study.
Topics: Absorptiometry, Photon; Asthma; Bone Density; Female; Humans; Osteoporosis; Osteoporosis, Postmenopa | 1992 |
Steroid-resistant bullous pemphigoid treated with cyclosporin A.
Topics: Aged; Cyclosporins; Drug Resistance; Female; Humans; Osteoporosis; Pemphigoid, Bullous; Prednisolone | 1991 |